nach oben

Erschienen in:

01.10.2015 | Magnetic Resonance

Veins in plaques of multiple sclerosis patients – a longitudinal magnetic resonance imaging study at 7 Tesla –

verfasst von: Assunta Dal-Bianco, Simon Hametner, Günther Grabner, Melanie Schernthaner, Claudia Kronnerwetter, Andreas Reitner, Clemens Vass, Karl Kircher, Eduard Auff, Fritz Leutmezer, Karl Vass, Siegfried Trattnig

Erschienen in: European Radiology | Ausgabe 10/2015

Einloggen, um Zugang zu erhalten

Abstract

Objective

To monitor the venous volumes in plaques of patients with multiple sclerosis (MS) compared to an age-matched control group over a period of 3.5 years.

Methods

Ten MS patients underwent an annual neurological examination and MRI. Susceptibility-weighted imaging (SWI) combined with fluid-attenuated inversion recovery (FLAIR) or FLAIR–like contrast at 7 Tesla (7 T) magnetic resonance imaging (MRI) was used for manual segmentation of veins in plaques, in the normal-appearing white matter (NAWM) and in location-matched white matter of 9 age-matched controls. Venous volume to tissue volume ratio was assessed for each time point in order to describe the dynamics of venous volumes in MS plaques over time.

Results

MS plaques, which were newly detected during the study period, showed significantly higher venous volumes compared to the preplaque area 1 year before plaque detection and the corresponding NAWM regions. Venous volumes in established MS plaques, which were present already in the first scans, were significantly higher compared to the NAWM and controls.

Conclusions

Our data underpin a relation of veins and plaque development in MS and reflect increased apparent venous calibers due to increased venous diameters or increased oxygen consumption in early MS plaques.

Key points

• Longitudinal 7 T Magnetic Resonance Imaging study of intralesional veins in MS patients.

• Venous volumes are significantly increased in newly detected and established MS plaques.

• Venous volumes in established MS plaques show a trend to decrease with time.

Nur mit Berechtigung zugänglich

Frischer JM, Bramow S, Dal-Bianco A, Lucchinetti CF, Rauschka H et al (2009) The relation between inflammation and neurodegeneration in multiple sclerosis brains. Brain 132:1175–1189PubMedCentralCrossRefPubMed

Rindfleisch E (1863) Histologisches Detail zur grauen Degeneration von Gehirn und Rückenmark. Arch Pathol Anat Physiol Klin Med (Virchow) 26:474–483CrossRef

Putnam T (1933) The pathogenesis of multiple sclerosis, a possible vascular factor. N Engl J Med 209:786–790CrossRef

Putnam T (1937) Vascular architecture of the lesions of multiple sclerosis. Arch Neurol Psychiatr 38:1–15CrossRef

Fog T (1964) On the vessel-plaque relationships in the brain in multiple sclerosis. Acta Neurol Scand Suppl 40(SUPPL 10):19–15

Waksman BH (1964) Local reaction of cellular hypersensitivity. Ann N Y Acad Sci 116:1045–51CrossRefPubMed

Adams CW (1988) Perivascular iron deposition and other vascular damage in multiple sclerosis. J Neurol Neurosurg Psychiatry 51:260–265PubMedCentralCrossRefPubMed

Tallantyre EC, Brookes MJ, Dixon JE, Morgan PS, Evangelou N et al (2008) Demonstrating the perivascular distribution of MS lesions in vivo with 7-Tesla MRI. Neurology 70:2076–2078CrossRefPubMed

Kollia K, Maderwald S, Putzki N, Schlamann M, Theysohn JM et al (2009) First clinical study on ultra-high-field MR imaging in patients with multiple sclerosis: comparison of 1.5 T and 7 T. AJNR Am J Neuroradiol 30:699–702CrossRefPubMed

10.

Mistry N, Dixon J, Tallantyre E, Tench C, Abdel-Fahim R et al (2013) Central veins in brain lesions visualized with high-field magnetic resonance imaging: a pathologically specific diagnostic biomarker for inflammatory demyelination in the brain. JAMA Neurol 70:623–628CrossRefPubMed

11.

Tallantyre EC, Morgan PS, Dixon JE, Al-Radaideh A, Brookes MJ et al (2009) A comparison of 3 T and 7 T in the detection of small parenchymal veins within MS lesions. Invest Radiol 44:491–494CrossRefPubMed

12.

Gaitan MI, Maggi P, Wohler J, Leibovitch E, Sati P et al (2014) Perivenular brain lesions in a primate multiple sclerosis model at 7-tesla magnetic resonance imaging. Mult Scler 20:64–71CrossRefPubMed

13.

Ge Y, Zohrabian VM, Grossman RI (2008) Seven-tesla magnetic resonance imaging: new vision of microvascular abnormalities in multiple sclerosis. Arch Neurol 65:812–816PubMedCentralPubMed

14.

Kau T, Taschwer M, Deutschmann H, Schonfelder M, Weber JR et al (2013) The "central vein sign": is there a place for susceptibility weighted imaging in possible multiple sclerosis? Eur Radiol 23:1956–1962CrossRefPubMed

15.

Sinnecker T, Bozin I, Dorr J, Pfueller CF, Harms L, et al. (2012) Periventricular venous density in multiple sclerosis is inversely associated with T2 lesion count: a 7 Tesla MRI study. Mult Scler 19(3):316–325

16.

Ge Y, Zohrabian VM, Osa EO, Xu J, Jaggi H et al (2009) Diminished visibility of cerebral venous vasculature in multiple sclerosis by susceptibility-weighted imaging at 3.0 tesla. J Magn Reson Imaging 29:1190–1194PubMedCentralCrossRefPubMed

17.

Grabner G, Dal-Bianco A, Schernthaner M, Vass K, Lassmann H et al (2011) Analysis of multiple sclerosis lesions using a fusion of 3.0 T FLAIR and 7.0 T SWI phase: FLAIR SWI. J Magn Reson Imaging: JMRI 33:543–549CrossRefPubMed

18.

Polman CH, Reingold SC, Edan G, Filippi M, Hartung HP et al (2005) Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann Neurol 58:840–846CrossRefPubMed

19.

Pruessner JC, Li LM, Serles W, Pruessner M, Collins DL et al (2000) Volumetry of hippocampus and amygdala with high-resolution MRI and three-dimensional analysis software: minimizing the discrepancies between laboratories. Cereb Cortex 10:433–442CrossRefPubMed

20.

Vincent RD JA, Sled JG, Baghdadi L, Neelin P, Evans AC (2004) MINC 2.0: a modality independent format for multidimensional medical images. Proceedings of the 10th Annual Meeting of the Organization for Human Brain Mapping, Budapest, Hungary (abstract WE 323)

21.

Rauscher A, Sedlacik J, Barth M, Haacke EM, Reichenbach JR (2005) Nonnvasive assessment of vascular architecture and function during modulated blood oxygenation using susceptibility weighted magnetic resonance imaging. Magn Reson Med: Off J Soc Magn Reson Med / Soc Magn Reson Med 54:87–95CrossRef

22.

Davies AL, Desai RA, Bloomfield PS, McIntosh PR, Chapple KJ et al (2013) Neurological deficits caused by tissue hypoxia in neuroinflammatory disease. Ann Neurol 74:815–825CrossRefPubMed

23.

Mahad DJ, Ziabreva I, Campbell G, Lax N, White K et al (2009) Mitochondrial changes within axons in multiple sclerosis. Brain 132:1161–1174PubMedCentralCrossRefPubMed

24.

Mews I, Bergmann M, Bunkowski S, Gullotta F, Bruck W (1998) Oligodendrocyte and axon pathology in clinically silent multiple sclerosis lesions. Mult Scler 4:55–62CrossRefPubMed

25.

Bjartmar C, Wujek JR, Trapp BD (2003) Axonal loss in the pathology of MS: consequences for understanding the progressive phase of the disease. J Neurol Sci 206:165–171CrossRefPubMed

26.

Kornek B, Storch MK, Weissert R, Wallstroem E, Stefferl A et al (2000) Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions. Am J Pathol 157:267–276PubMedCentralCrossRefPubMed

27.

Frischer JM, Bramow S, Dal-Bianco A, Lucchinetti CF, Rauschka H et al (2009) The relation between inflammation and neurodegeneration in multiple sclerosis brains. Brain J Neurol 132:1175–1189CrossRef

28.

Bakshi R, Miletich RS, Kinkel PR, Emmet ML, Kinkel WR (1998) High-resolution fluorodeoxyglucose positron emission tomography shows both global and regional cerebral hypometabolism in multiple sclerosis. J Neuroimaging 8:228–234CrossRefPubMed

29.

Brooks DJ, Leenders KL, Head G, Marshall J, Legg NJ et al (1984) Studies on regional cerebral oxygen utilisation and cognitive function in multiple sclerosis. J Neurol Neurosurg Psychiatry 47:1182–1191PubMedCentralCrossRefPubMed

30.

Blinkenberg M, Rune K, Jensen CV, Ravnborg M, Kyllingsbaek S et al (2000) Cortical cerebral metabolism correlates with MRI lesion load and cognitive dysfunction in MS. Neurology 54:558–564CrossRefPubMed

31.

Varga AW, Johnson G, Babb JS, Herbert J, Grossman RI et al (2009) White matter hemodynamic abnormalities precede sub-cortical gray matter changes in multiple sclerosis. J Neurol Sci 282:28–33PubMedCentralCrossRefPubMed

32.

Adhya S, Johnson G, Herbert J, Jaggi H, Babb JS et al (2006) Pattern of hemodynamic impairment in multiple sclerosis: dynamic susceptibility contrast perfusion MR imaging at 3.0 T. Neuroimage 33:1029–1035PubMedCentralCrossRefPubMed

33.

Ge Y, Law M, Johnson G, Herbert J, Babb JS et al (2005) Dynamic susceptibility contrast perfusion MR imaging of multiple sclerosis lesions: characterizing hemodynamic impairment and inflammatory activity. AJNR Am J Neuroradiol 26:1539–1547PubMed

34.

Law M, Saindane AM, Ge Y, Babb JS, Johnson G et al (2004) Microvascular abnormality in relapsing-remitting multiple sclerosis: perfusion MR imaging findings in normal-appearing white matter. Radiology 231:645–652CrossRefPubMed

35.

D'Haeseleer M, Cambron M, Vanopdenbosch L, De Keyser J (2011) Vascular aspects of multiple sclerosis. Lancet Neurol 10:657–666CrossRefPubMed

36.

Wuerfel J, Sinnecker T, Ringelstein EB, Jarius S, Schwindt W et al (2012) Lesion morphology at 7 Tesla MRI differentiates Susac syndrome from multiple sclerosis. Mult Scler 18:1592–1599CrossRefPubMed

37.

Bagnato F, Hametner S, Yao B, van Gelderen P, Merkle H et al (2011) Tracking iron in multiple sclerosis: a combined imaging and histopathological study at 7 Tesla. Brain 134:3602–3615CrossRefPubMed

38.

Gaitan MI, de Alwis MP, Sati P, Nair G, Reich DS (2013) Multiple sclerosis shrinks intralesional, and enlarges extralesional, brain parenchymal veins. Neurology 80:145–151PubMedCentralCrossRefPubMed

39.

Muller K, Kuchling J, Dorr J, Harms L, Ruprecht K, et al. (2014) Detailing intra-lesional venous lumen shrinking in multiple sclerosis investigated by sFLAIR MRI at 7-T. J Neurol 261(10):2032–2036

40.

Zamboni P, Galeotti R, Menegatti E, Malagoni AM, Tacconi G et al (2009) Chronic cerebrospinal venous insufficiency in patients with multiple sclerosis. J Neurol Neurosurg Psychiatry 80:392–399PubMedCentralCrossRefPubMed

41.

Macgowan CK, Chan KY, Laughlin S, Marrie RA, Banwell B (2014) Cerebral arterial and venous blood flow in adolescent multiple sclerosis patients and age-matched controls using phase contrast MRI. J Magn Reson Imaging: JMRI 40:341–347CrossRefPubMed

42.

Barkhof F, Wattjes MP (2013) Multiple sclerosis: CCSVI deconstructed and discarded. Nat Rev Neurol 9:661–662CrossRefPubMed

43.

Meyer-Schwickerath R, Haug C, Hacker A, Fink F, Seidel D et al (2011) Intracranial venous pressure is normal in patients with multiple sclerosis. Mult Scler 17:637–638CrossRefPubMed

44.

Zivadinov R, Poloni GU, Marr K, Schirda CV, Magnano CR et al (2011) Decreased brain venous vasculature visibility on susceptibility-weighted imaging venography in patients with multiple sclerosis is related to chronic cerebrospinal venous insufficiency. BMC Neurol 11:128PubMedCentralCrossRefPubMed

Titel: Veins in plaques of multiple sclerosis patients – a longitudinal magnetic resonance imaging study at 7 Tesla –
verfasst von: Assunta Dal-Bianco
Simon Hametner
Günther Grabner
Melanie Schernthaner
Claudia Kronnerwetter
Andreas Reitner
Clemens Vass
Karl Kircher
Eduard Auff
Fritz Leutmezer
Karl Vass
Siegfried Trattnig
Publikationsdatum: 01.10.2015
Verlag: Springer Berlin Heidelberg
Erschienen in: European Radiology / Ausgabe 10/2015
Print ISSN: 0938-7994
Elektronische ISSN: 1432-1084
DOI: https://doi.org/10.1007/s00330-015-3719-y

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Veins in plaques of multiple sclerosis patients – a longitudinal magnetic resonance imaging study at 7 Tesla –